DYRK2 and carcinoma: These reports suggest that the RAM domain plays a key role in promoting the interaction between N1‐ICD and DYRK2 and therefore, DYRK2 modulation by chemotherapeutic agents may have a strong effect on the viability, motility, migration, and invasion capacity of carcinomas expressing NOTCH1.50